Galapagos NV
GLPG
#4563
Rank
ยฃ1.58 B
Marketcap
ยฃ23.71
Share price
-0.57%
Change (1 day)
12.27%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -ยฃ0.18

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -ยฃ0.25. In 2024 the company made an earnings per share (EPS) of ยฃ0.87 a decrease over its 2023 EPS that were of ยฃ2.66.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ0.18-120.9%
2024ยฃ0.87-67.16%
2023ยฃ2.66-199.64%
2022-ยฃ2.6799.03%
2021-ยฃ1.34-68.98%
2020-ยฃ4.33-298.06%
2019ยฃ2.19-554.64%
2018-ยฃ0.48-77.18%
2017-ยฃ2.11-326.21%
2016ยฃ0.93-134.19%
2015-ยฃ2.72-371.34%
2014ยฃ1.00-445.98%
2013-ยฃ0.2932.88%
2012-ยฃ0.22-82.07%
2011-ยฃ1.22-817.9%
2010ยฃ0.1712.73%
2009ยฃ0.15-120.79%
2008-ยฃ0.72-37.67%
2007-ยฃ1.1639.64%
2006-ยฃ0.8328.17%
2005-ยฃ0.656.25%
2004-ยฃ0.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
ยฃ2.28-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
ยฃ7.84-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ2.78-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
ยฃ1.01-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-ยฃ1.10 333.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ6.05-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.47-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
ยฃ2.70-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
ยฃ5.70-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA